Jensen L E, Whitehead A S
Department of Genetics and Biotechnology Institute, Trinity College, Dublin, Ireland.
J Immunol Methods. 1998 Jun 1;215(1-2):45-58. doi: 10.1016/s0022-1759(98)00085-4.
Competitive reverse transcription polymerase chain reaction (RT-PCR) is an increasingly used method for quantifying RNA. The technique involves co-amplification from test RNA with an internal standard using common primers in a single reaction. The standard competes for primers and enzyme and it is therefore referred to as a competitor. A RT-PCR polycompetitor for use in quantifying acute phase serum amyloid A, constitutive serum amyloid A, serum amyloid P component, C-reactive protein, apolipoprotein A1, apolipoprotein A2, glyceraldehyde-3-phosphate dehydrogenase and beta-actin mRNAs has been generated and used in quantitative PCR. The polycompetitor was synthesised from ten oligonucleotides of 77-90 bases using primer extension and contains sequences which permit amplification using priming sites that are present in both hnRNA (pre-mRNA) and mRNA. The polycompetitor was cloned into the expression vector pSP64(polyA) and a polycompetitor transcript with a poly(A)-tail sequence at the 3'-end was generated by in vitro transcription. The poly(A)-tail sequence allows the option of performing reverse transcription using oligo(dT) in addition to directed reverse transcription using the specific 3'-reverse PCR primers. cDNA products generated from amplification of the internal polycompetitor standard and endogenous RNA species were separated by capillary electrophoresis and quantified by UV absorbance at 254 nm. Reproducibility was determined to be very high when starting ratios of internal standard and target mRNA are at an approximate equivalence point. Relative standard deviations were less than 5% between independent RT-PCR reactions with the same sample mix of internal standard and total RNA. Applying the method to total RNA samples harvested at various timepoints following cytokine induction of acute phase mRNAs in endothelial cells demonstrated that quantitative readout from the RT-PCR method correlates well with that obtained from Northern-blotting and is at least 100-fold more sensitive. This method will be useful for studying regulation of acute phase proteins in in vitro tissue culture experiments and may also be applied to clinical tissue samples from patients with inflammatory diseases.
竞争性逆转录聚合酶链反应(RT-PCR)是一种越来越常用的RNA定量方法。该技术涉及在单一反应中使用通用引物从测试RNA与内标进行共扩增。内标与引物和酶竞争,因此被称为竞争物。一种用于定量急性期血清淀粉样蛋白A、组成型血清淀粉样蛋白A、血清淀粉样蛋白P成分、C反应蛋白、载脂蛋白A1、载脂蛋白A2、甘油醛-3-磷酸脱氢酶和β-肌动蛋白mRNA的RT-PCR多竞争物已被制备并用于定量PCR。该多竞争物由10个77-90个碱基的寡核苷酸通过引物延伸合成,包含允许使用存在于核不均一RNA(前体mRNA)和mRNA中的引物位点进行扩增的序列。该多竞争物被克隆到表达载体pSP64(polyA)中,并通过体外转录产生在3'-末端具有聚腺苷酸尾序列的多竞争物转录本。聚腺苷酸尾序列允许除了使用特异性3'-反向PCR引物进行定向逆转录外,还可以选择使用oligo(dT)进行逆转录。由内部多竞争物标准和内源性RNA物种扩增产生的cDNA产物通过毛细管电泳分离,并通过254nm处的紫外吸光度进行定量。当内标和靶mRNA的起始比例处于近似等效点时,重现性被确定为非常高。在相同的内标和总RNA样品混合物的独立RT-PCR反应之间,相对标准偏差小于5%。将该方法应用于内皮细胞中急性期mRNA细胞因子诱导后不同时间点收获的总RNA样品,结果表明RT-PCR方法的定量读数与Northern印迹法获得的结果相关性良好,并且灵敏度至少高100倍。该方法将有助于在体外组织培养实验中研究急性期蛋白的调控,也可应用于炎症性疾病患者的临床组织样本。